NASDAQ Insider Buying: Prospect Capital (NASDAQ:PSEC), CyrusOne (NASDAQ:CONE), National Penn Bancshares (NASDAQ:NPBC), Insys Therapeutics (NASDAQ:INSY), Bank Of The Ozarks (NASDAQ:OZRK)

Technology Stocks News 14

Prospect Capital Corp. (NASDAQ:PSEC) CEO John F. Barry purchased 100,000 shares of the stock in a transaction dated Friday, June 13th. The stock was purchased at an average cost of $10.37 per share, for a total transaction of $1,037,000.00. Following the completion of the purchase, the chief executive officeronline.wsj.comchief executive officer now directly owns 4,110,959 shares in the company, valued at approximately $42,630,645. Prospect Capital Corporation (NASDAQ:PSEC) stock performance was 0.29% in last session and finished the day at $10.37. Traded volume was 3.87million shares in the last session and the average volume of the stock remained 5.44million shares. The beta of the stock remained 1.01. Prospect Capital Corporation (NASDAQ:PSEC) insider ownership is 1.10%.

CyrusOne Inc (NASDAQ:CONE) CEO Gary J. Wojtaszek bought 10,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, June 13th. The stock was purchased at an average cost of $22.69 per share, for a total transaction of $226,900.00. Following the transaction, the chief executive officer now directly owns 490,965 shares of the company’s stock, valued at approximately $11,139,996. CyrusOne Inc (NASDAQ:CONE) rose 1.60 percent to $23.44 Wednesday on volume of 869,403.00million shares. The intra-day range of the stock was $21.98 to $23.77. CyrusOne Inc (NASDAQ:CONE) has a market capitalization of $531.61million.

National Penn Bancshares (NASDAQ:NPBC) Director Christian Iv Martin purchased 1,024 shares of the company’s stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $9.77 per share, with a total value of $10,004.48. Following the acquisition, the director now directly owns 363,382 shares of the company’s stock, valued at approximately $3,550,242. National Penn Bancshares (NASDAQ:NPBC)’s stock on June 18, 2014 reported a increase of 0.19% to the closing price of $10.52. Its fifty two weeks range is $9.50 -$11.63. The total market capitalization recorded $1.46billion. The overall volume in the last trading session was 811,286.00million shares. In its share capital, NPBC has 139.17million outstanding shares.

Insys Therapeutics Inc (NASDAQ:INSY) Director John N. Kapoor bought 5,000 shares of Insys Therapeutics stock in a transaction dated Monday, June 16th. The stock was purchased at an average cost of $26.13 per share, with a total value of $130,650.00. Following the completion of the transaction, the director now directly owns 15,991 shares of the company’s stock, valued at approximately $417,845. On Wednesday, shares of Insys Therapeutics Inc (NASDAQ:INSY) dropped -4.71% to close the day at $28.30. Company return on investment (ROI) is 52.10% and its monthly performance is recorded as 6.59%. Insys Therapeutics Inc (NASDAQ:INSY) quarterly revenue growth is -39.06%.

Bank of the Ozarks Inc (NASDAQ:OZRK) Director Jean Arehart acquired 2,000 shares of the company’s stock in a transaction dated Friday, June 13th. The shares were purchased at an average price of $62.87 per share, with a total value of $125,740.00. Following the completion of the transaction, the director now directly owns 18,200 shares in the company, valued at approximately $1,144,234. Bank Of The Ozarks Inc (NASDAQ:OZRK) stock performance was 0.32% in last session and finished the day at $65.23. Traded volume was 457,717.00million shares in the last session and the average volume of the stock remained 225.46K shares. The beta of the stock remained 1.14. Bank Of The Ozarks Inc (NASDAQ:OZRK) insider ownership is 2.60%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone